Elevance Health, Inc. (LON:0HG8)
London · Delayed Price · Currency is GBP · Price in USD 344.74
+0.75 (0.22%)
At close: Jan 30, 2026
Elevance Health Market Cap
Elevance Health has a market cap or net worth of 56.01 billion as of January 30, 2026. Its market cap has decreased by -24.09% in one year.
Market Cap
56.01B
Enterprise Value
72.55B
Revenue
147.95B
Ranking
n/a
PE Ratio
13.31
Stock Price
344.74
Market Cap Chart
Since October 30, 2001, Elevance Health's market cap has increased from 2.89B to 56.01B, an increase of 1,836.48%. That is a compound annual growth rate of 12.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2026 | 56.01B | -3.24% |
| Dec 31, 2025 | 57.88B | -15.30% |
| Dec 31, 2024 | 68.34B | -21.43% |
| Dec 29, 2023 | 86.98B | -14.45% |
| Dec 30, 2022 | 101.68B | 22.37% |
| Dec 31, 2021 | 83.09B | 42.06% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 210.92B |
| GSK plc | 75.29B |
| Haleon | 33.75B |
| Smith & Nephew | 10.55B |
| Convatec Group | 4.48B |
| Hikma Pharmaceuticals | 3.39B |
| Genus | 2.11B |
| HUTCHMED (China) | 1.89B |